PUBLIC HEALTH ASSESSMENT
PANTEX PLANT
AMARILLO, CARSON COUNTY, TEXAS
Health Outcome Data Tables
| Table 1 Summary of Birth Defect Check Box Categories in the Texas Birth Certificate and Fetal Death Certificate (11) | |
| Category of Birth Defect | Description of Birth Defect Category |
| Anencephalus | Congenital absence of the cranial vault, with cerebral hemispheres completely missing or reduced to small masses attached to the base of the skull. |
| Spina Bifida / meningocele | A developmental anomaly characterized by defective closure of the bony encasement of the spinal cord, through which the cord and meninges may or may not protrude. |
| Hydrocephalus | A condition characterized by abnormal accumulation of fluid in the cranial vault, accompanied by enlargement of the head. |
| Microcephalus | Abnormal smallness of the head. |
| Other central nervous system anomalies | |
| Heart malformations | Malformations of the heart. |
| Other circulatory / respiratory anomalies | |
| Rectal atresia / stenosis | Atresia (imperforation; absence or closure of normal opening) or stenosis (narrowing) of the rectum or anus. |
| Tracheo-esophageal fistula / esophageal atresia | Tracheo-esophageal fistula: opening between the trachea and esophagus. Atresia: absence of open canal of the esophagus. |
| Omphalocele / gastroschisis | Protrusion at birth of part of the intestine through a large defect in the abdominal wall. In omphalocele, usually covered by a thin membrane. Different etiologies. |
| Other gastrointestinal anomalies | |
| Malformed genitalia | |
| Renal agenesis | Congenital absence of one or both kidneys. |
| Other urogenital anomalies | |
| Cleft lip/palate | Fissure or gap in the upper lip and/or palate. |
| Polydactyly / syndactyly | Polydactyly: too many fingers or toes. Syndactyly: fingers or toes fused together. |
| Limb reductions | Parts of hand, arm, foot, or legs missing. |
| Club foot | A deformity of the foot in which it is twisted out of shape or position, referred to medically as talipes. |
| Diaphragmatic hernia | The protrusion of an organ through a defect in the diaphragm. |
| Other musculoskeletal / integumental anomalies | |
| Down syndrome | A chromosomal abnormality characterized by moderate to severe mental retardation, epicanthal folds in eyes, sloping forehead, flat-bridged nose, short phalanges. Caused by an extra chromosome 21 (trisomy 21). Old name: mongolism (due to characteristic eye features). |
| Other chromosomal anomalies | Several, including trisomy 13 (Patau syndrome), trisomy 18 (Edward syndrome). |
| Other congenital anomalies | Catchall category, if something present that doesn't fit into one of the categories above. |
References: California Birth Defects Monitoring Program. A
glossary of birth defects terminology. 1983.
Goodman RM, Gorlin RJ. The Malformed Infant and Child: An Illustrated
Guide (Glossary). New York; Oxford University Press, 1983.
The following table was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:
Agency for Toxic Substances and Disease Registry
Division of Health Assessment and Consultation
Attn: Chief, Program Evaluation, Records, and Information Services Branch E-56
1600 Clifton Road NE, Atlanta, Georgia 30333
The following table was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:
Agency for Toxic Substances and Disease Registry
Division of Health Assessment and Consultation
Attn: Chief, Program Evaluation, Records, and Information Services Branch E-56
1600 Clifton Road NE, Atlanta, Georgia 30333
Appendix E
|
Table 4 Birth Defects Zip Code Analysis 1990-1994 | ||||
| CONDITION | OBS | EXP | OER | 95% CI |
| Microcephalus | 6 | 0.32 | 18.75 | 6.88 - 40.88 |
| Heart Malformations | 18 | 3.49 | 5.16 | 3.06 - 8.15 |
| Other Circulatory/Respiratory Anomalies | 21 | 2.40 | 8.75 | 5.24 - 13.39 |
| Tracheo-Esophageal Fistula/Esophageal Atresia | 2 | 0.28 | 7.14 | 0.86 - 25.79 |
| Other Gastrointestinal Anomalies | 3 | 0.74 | 4.05 | 0.84 - 11.84 |
| Malformed Genitalia | 7 | 2.75 | 2.55 | 1.02 - 5.24 |
| Other Urogenital Anomalies | 14 | 2.54 | 5.51 | 3.01 - 9.26 |
| Club Foot | 9 | 1.91 | 4.71 | 2.16 - 8.95 |
| Other Muscular skeletal/Integumental Anomalies | 17 | 4.45 | 3.82 | 2.23 - 6.11 |
The following table was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:
Agency for Toxic Substances and Disease Registry
Division of Health Assessment and Consultation
Attn: Chief, Program Evaluation, Records, and Information Services Branch E-56
1600 Clifton Road NE, Atlanta, Georgia 30333
The following table was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:
Agency for Toxic Substances and Disease Registry
Division of Health Assessment and Consultation
Attn: Chief, Program Evaluation, Records, and Information Services Branch E-56
1600 Clifton Road NE, Atlanta, Georgia 30333
The following table was not available in electronic format for conversion to HTML at the time of preparation of this document. To obtain a hard copy of the document, please contact:
Agency for Toxic Substances and Disease Registry
Division of Health Assessment and Consultation
Attn: Chief, Program Evaluation, Records, and Information Services Branch E-56
1600 Clifton Road NE, Atlanta, Georgia 30333
Appendix E
| Table 8 Observed to Expected Ratios for Low Birth Weight by County, 1990-1994 | ||||
| COUNTY | OBS | EXP | OER | 95% CI |
| Armstrong | 12 | 7.67 | 1.57 | 0.81 - 2.74 |
| Carson | 40 | 26.90 | 1.491 | 1.06 - 2.022 |
| Potter | 919 | 711.21 | 1.291 | 1.21 - 1.38 |
| Randall | 430 | 444.29 | 0.97 | 0.88 - 1.06 |
1 Significantly higher (at the 5% level) than expected.
| Table
9 Armstrong County 1985-1993 Cancer Incidence and Race-Adjusted Standardized Incidence Ratios (13) |
||||
| MALES | ||||
| Site | Observed |
Expected |
SIR | 95% CI |
| Lung | 7 |
12.47 |
0.56 |
0.23-1.16 |
| Bone | 0 |
0.09 |
- |
- |
| Prostate | 8 |
22.30 |
0.36* |
0.15- 0.71 |
| Brain | 1 |
0.96 |
1.04 |
0.03-5.80 |
| Thyroid | 0 |
0.31 |
- |
- |
| Leukemia | 2 |
1.90 |
1.05 |
0.13-3.80 |
| All Sites | 52 |
72.17 |
0.72* |
0.54- 0.94 |
| FEMALES | ||||
| Site | Observed | Expected | SIR | 95% CI |
| Lung | 2 |
8.66 |
0.23* |
0.03- 0.83 |
| Bone | 0 |
0.11 |
- |
- |
| Breast | 6 |
18.47 |
0.32* |
0.12- 0.71 |
| Brain | 0 |
0.79 |
- |
- |
| Thyroid | 0 |
0.72 |
- |
- |
| Leukemia | 1 |
1.37 |
0.73 |
0.02-4.07 |
| All Sites | 26 |
61.44 |
0.42* |
0.28- 0.62 |
Note: The SIR (standardized incidence
ratio) is defined as the number of observed cases divided by the number of expected
cases. The latter is based on race-, sex-, and age-specific cancer incidence
rates for California, 1988-1992 (cancer incidence rates for five regions of
Texas, 1985-1991 were used to calculate bone cancer expected cases because California
rates were not available).
* Significantly lower (at the 5% level)
than expected.
Appendix E
| Table
10 Carson County 1985-1993 Cancer Incidence and Race-Adjusted Standardized Incidence Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SIR | 95% CI |
| Lung | 28 |
30.86 |
0.91 |
0.60-1.31 |
| Bone | 0 |
0.28 |
- |
- |
| Prostate | 46 |
52.40 |
0.88 |
0.64-1.17 |
| Brain | 0 |
2.71 |
- |
- |
| Thyroid | 0 |
0.93 |
- |
- |
| Leukemia | 5 |
4.83 |
1.04 |
0.34-2.42 |
| All Sites | 150 |
178.88 |
0.84* |
0.71- 0.98 |
| FEMALES | ||||
| Site | Observed | Expected | SIR | 95% CI |
| Lung | 10 |
21.65 |
0.46* |
0.22- 0.85 |
| Bone | 1 |
0.32 |
3.13 |
0.08-17.41 |
| Breast | 35 |
48.58 |
0.72 |
0.50-1.00 |
| Brain | 3 |
2.18 |
1.38 |
0.28-4.02 |
| Thyroid | 1 |
0.08 |
12.50 |
0.32-69.64 |
| Leukemia | 6 |
3.40 |
1.76 |
0.65-3.84 |
| All Sites | 136 |
156.14 |
0.87 |
0.73-1.03 |
Note: The SIR (standardized incidence
ratio) is defined as the number of observed cases divided by the number of expected
cases. The latter is based on race-, sex-, and age-specific cancer incidence
rates for California, 1988-1992 (cancer incidence rates for five regions of
Texas, 1985-1991 were used to calculate bone cancer expected cases because California
rates were not available).
* Significantly lower (at the 5% level)
than expected.
Appendix E
| Table
11 Potter and Randall Counties Combined 1985-1993 Cancer Incidence and Race-Adjusted Standardized Incidence Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SIR | 95% CI |
| Lung | 624 |
626.49 |
0.99 |
0.92-1.08 |
| Bone | 7 |
7.18 |
0.97 |
0.39-2.01 |
| Prostate | 879 |
1011.32 |
0.87* |
0.81- 0.93 |
| Brain | 53 |
62.04 |
0.85 |
0.64-1.12 |
| Thyroid | 20 |
22.04 |
0.91 |
0.55-1.40 |
| Leukemia | 103 |
103.00 |
1.00 |
0.82-1.21 |
| All Sites | 3460 |
3662.52 |
0.94* |
0.91- 0.97 |
| FEMALES | ||||
| Site | Observed | Expected | SIR | 95% CI |
| Lung | 372 |
493.84 |
0.75* |
0.68- 0.83 |
| Bone | 4 |
8.48 |
0.47 |
0.13-1.21 |
| Breast | 906 |
1148.00 |
0.79* |
0.74- 0.84 |
| Brain | 42 |
53.77 |
0.78 |
0.56-1.06 |
| Thyroid | 67 |
62.33 |
1.07 |
0.83-1.37 |
| Leukemia | 88 |
82.37 |
1.07 |
0.86-1.32 |
| All Sites | 4015 |
3693.56 |
1.09** |
1.06-1.12 |
Note: The SIR (standardized incidence
ratio) is defined as the number of observed cases divided by the number of expected
cases. The latter is based on race-, sex-, and age-specific cancer incidence
rates for California, 1988-1992 (cancer incidence rates for five regions of
Texas, 1985-1991 were used to calculate bone cancer expected cases because California
rates were not available).
* Significantly lower (at the 5% level)
than expected.
** Significantly higher (at the 5% level)
than expected.
Appendix E
| TABLE
12 Armstrong, Carson, and Potter/Randall Counties 1985-1993 Leukemia by Cell Type and Race-Adjusted Standardized Incidence Ratios (13) |
||||
| MALES | ||||
| County/Site# | Observed | Expected | SIR* | 95% CI |
| ARMSTRONG ALL AML CLL CML |
0 0 2 0 |
0.2 0.5 0.6 0.3 |
- - 3.1 - |
- - 0.4 -11.3 - |
| CARSON ALL AML CLL CML |
1 0 2 0 |
0.5 1.2 1.5 0.7 |
1.9 - 1.3 - |
0.0 -10.5 - 0.2 - 4.7 - |
| POTTER/RANDALL ALL AML CLL CML |
12 19 46 13 |
15.0 25.9 30.1 13.9 |
0.8 0.7 1.5** 0.9 |
0.4 - 1.4 0.4 - 1.2 1.1 - 2.0 0.5 - 1.6 |
Note: The SIR (standardized incidence ratio)
is defined as the number of observed cases divided by the number of expected
cases. The latter is based on race-, sex-, and age-specific cancer incidence
rates for California during the period 1988-1993.
* The SIR has been rounded to the
first decimal place.
** Significantly higher (at the 5%
level) than expected.
# Acute lymphocytic leukemia
(ALL), acute myelocytic leukemia (AML), chronic lymphocytic leukemia (CLL),
and chronic myelocytic leukemia (CML)
| Table
13 Armstrong, Carson, and Potter/Randall Counties 1985-1993 Leukemia by Cell Type and Race-Adjusted Standardized Incidence Ratios (13) |
||||
|
FEMALES | ||||
| County/Site# | Observed | Expected | SIR* | 95% CI |
| ARMSTRONG ALL AML CLL CML |
0 |
0.1 0.4 0.5 0.2 |
- - 2.2 - |
- - 0.1 -12.1 - |
| CARSON ALL AML CLL CML | 0 2 2 0 |
0.4 1.0 1.1 0.4 |
- 2.1 1.9 - |
- 0.3 - 7.5 0.2 - 6.8 - |
| POTTER/RANDALL ALL AML CLL CML | 10 24 33 11 |
11.8 23.8 23.9 9.6 |
0.8 1.0 1.4 1.1 |
0.4 - 1.6 0.7 - 1.5 1.0 -1.9 0.6 - 2.1 |
Note: The SIR (standardized incidence ratio) is defined as
the number of observed cases divided by the number of expected cases. The latter
is based on race-, sex-, and age-specific cancer incidence rates for California
during the period 1988-1993.
* The SIR has been rounded to the first decimal place.
#
Acute lymphocytic leukemia (ALL), acute myelocytic leukemia (AML), chronic lymphocytic
leukemia (CLL), and chronic myelocytic leukemia (CML)
Appendix E
| Table
14 Armstrong County 1985-1994 Cancer Deaths and Race-Adjusted Standardized Mortality Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 10 |
13.29 |
0.75 |
0.36-1.38 |
| Bone | 1 |
0.10 |
10.00 |
0.25-55.71 |
| Prostate | 3 |
4.55 |
0.66 |
0.14-1.93 |
| Brain | 1 |
0.83 |
1.20 |
0.03-6.71 |
| Thyroid | 0 |
0.04 |
- |
- |
| Leukemia | 2 |
1.51 |
1.32 |
0.16-4.78 |
| All Sites | 32 |
37.47 |
0.85 |
0.58-1.21 |
| FEMALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 3 |
6.63 |
0.45 |
0.09-1.32 |
| Bone | 0 |
0.08 |
- |
- |
| Breast | 5 |
4.51 |
1.11 |
0.36-2.59 |
| Brain | 0 |
0.68 |
- |
- |
| Thyroid | 0 |
0.07 |
- |
- |
| Leukemia | 1 |
1.11 |
0.90 |
0.02-5.02 |
| All Sites | 19 |
28.43 |
0.67 |
0.40-1.04 |
Note: The SMR (standardized mortality ratio) is defined as the number of observed deaths divided by the number of expected deaths. The latter is based on race-, sex-, and age-specific cancer mortality rates for Texas during the period 1985-1994.
Appendix E
| Table
15 Carson County 1985-1994 Cancer Deaths and Race-Adjusted Standardized Mortality Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 24 |
32.60 |
0.74 |
0.47-1.10 |
| Bone | 0 |
0.28 |
- |
- |
| Prostate | 6 |
10.08 |
0.60 |
0.22-1.30 |
| Brain | 2 |
2.21 |
0.91 |
0.11-3.27 |
| Thyroid | 0 |
0.10 |
- |
- |
| Leukemia | 6 |
3.70 |
1.62 |
0.60-3.53 |
| All Sites | 68 |
90.73 |
0.75* |
0.58- 0.95 |
| FEMALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 8 |
16.34 |
0.49* |
0.21- 0.96 |
| Bone | 0 |
0.20 |
- |
- |
| Breast | 6 |
11.48 |
0.52 |
0.19-1.14 |
| Brain | 4 |
1.78 |
2.25 |
0.61-5.75 |
| Thyroid | 0 |
0.16 |
- |
- |
| Leukemia | 6 |
2.63 |
2.28 |
0.84-4.97 |
| All Sites | 55 |
68.82 |
0.80 |
0.60-1.04 |
Note: The SMR (standardized mortality
ratio) is defined as the number of observed deaths divided by the number of
expected deaths. The latter is based on race-, sex-, and age-specific cancer
mortality rates for Texas during the period 1985-1994.
* Significantly lower (at the
5% level) than expected.
Appendix
E
| Table
16 Potter County 1985-1994 Cancer Deaths and Race-Adjusted Standardized Mortality Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 384 |
368.52 |
1.04 |
0.94-1.15 |
| Bone | 1 |
3.34 |
0.30 |
0.01-1.67 |
| Prostate | 158 |
117.52 |
1.34* |
1.14-1.57 |
| Brain | 29 |
25.05 |
1.15 |
0.78-1.66 |
| Thyroid | 1 |
1.24 |
0.81 |
0.02-4.49 |
| Leukemia | 43 |
42.49 |
1.01 |
0.73-1.36 |
| All Sites | 1140 |
1044.87 |
1.09* |
1.03-1.16 |
| FEMALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 211 |
211.36 |
1.00 |
0.87-1.14 |
| Bone | 4 |
2.89 |
1.38 |
0.38-3.54 |
| Breast | 175 |
156.19 |
1.12 |
0.96-1.30 |
| Brain | 31 |
23.27 |
1.33 |
0.91-1.89 |
| Thyroid | 2 |
2.39 |
0.84 |
0.10-3.02 |
| Leukemia | 39 |
37.23 |
1.05 |
0.74-1.43 |
| All Sites | 986 |
946.07 |
1.04 |
0.98-1.11 |
Note:
The SMR (standardized mortality ratio) is defined as the number of observed
deaths divided by the number of expected deaths. The latter is based on race-,
sex-, and age-specific cancer mortality rates for Texas during the period 1985-1994.
*
Significantly higher (at the 5% level) than expected.
Appendix
E
| Table
17 Randall County 1985-1994 Cancer Deaths and Race-Adjusted Standardized Mortality Ratios (13) |
||||
| MALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 202 |
292.98 |
0.69* |
0.60- 0.79 |
| Bone | 1 |
2.76 |
0.36 |
0.01-2.02 |
| Prostate | 101 |
75.85 |
1.33** |
1.08-1.62 |
| Brain | 25 |
23.00 |
1.09 |
0.70-1.60 |
| Thyroid | 0 |
0.97 |
- |
- |
| Leukemia | 17 |
33.34 |
0.51* |
0.30-0.82 |
| All Sites | 693 |
802.85 |
0.86* |
0.80- 0.93 |
| FEMALES | ||||
| Site | Observed | Expected | SMR | 95% CI |
| Lung | 129 |
161.01 |
0.80* |
0.67- 0.95 |
| Bone | 1 |
2.18 |
0.46 |
0.01-2.56 |
| Breast | 108 |
119.44 |
0.90 |
0.74-1.09 |
| Brain | 22 |
19.10 |
1.15 |
0.72-1.74 |
| Thyroid | 1 |
1.51 |
0.66 |
0.02-3.69 |
| Leukemia | 20 |
25.92 |
0.77 |
0.47-1.19 |
| All Sites | 601 |
676.20 |
0.89* |
0.82- 0.96 |
Note: The SMR (standardized mortality
ratio) is defined as the number of observed deaths divided by the number of
expected deaths. The latter is based on race-, sex-, and age-specific cancer
mortality rates for Texas during the period 1985-1994.
* Significantly lower (at the
5% level) than expected.
** Significantly
higher (at the 5% level) than expected.
Appendix
E
| Table
18 Armstrong County 1980-1994 Selected Diseases and Age, Race-Adjusted Standardized Mortality Ratios |
||||
|
Males | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
0.095 |
-- |
-- |
| Multiple Sclerosis |
0 |
0.069 |
-- |
-- |
| Amyotrophic Lateral Sclerosis |
0 |
0.343 |
-- |
-- |
| Lupus |
0 |
0.097 |
-- |
-- |
|
Females | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
0.050 |
-- |
-- |
| Multiple Sclerosis |
0 |
0.105 |
-- |
-- |
| Amyotrophic Lateral Sclerosis |
0 |
0.293 |
-- |
-- |
| Lupus |
0 |
0.302 |
-- |
-- |
| Table
19 Carson County 1980-1994 Selected Diseases and Age, Race-Adjusted Standardized Mortality Ratios |
||||
|
Males | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
3 |
0.310 |
9.68* |
1.99 - 28.25 |
| Multiple Sclerosis |
0 |
0.196 |
-- |
-- |
| Amyotrophic Lateral Sclerosis |
0 |
0.908 |
-- |
-- |
| Lupus |
0 |
0.266 |
-- |
-- |
|
Females | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
0.142 |
-- |
-- |
| Multiple Sclerosis |
0 |
0.309 |
-- |
-- |
| Amyotrophic Lateral Sclerosis |
0 |
0.758 |
-- |
-- |
| Lupus |
2 |
0.830 |
2.41 |
0.29 - 8.70 |
* Significantly higher (at the 5% level) than expected.
Appendix E
| Table 20 Potter County 1980-1994 Selected Diseases and Age, Race-Adjusted Standardized Mortality Ratios |
||||
|
Males | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
9 |
3.95 |
2.28* |
1.04 - 4.33 |
| Multiple Sclerosis |
5 |
2.12 |
2.36 |
0.76 - 5.50 |
| Amyotrophic Lateral Sclerosis |
17 |
9.88 |
1.72 |
1.00 - 2.76 |
| Lupus |
5 |
3.68 |
1.36 |
0.44 - 3.17 |
|
Females | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
1.83 |
-- |
-- |
| Multiple Sclerosis |
5 |
3.97 |
1.26 |
0.41 - 2.93 |
| Amyotrophic Lateral Sclerosis |
12 |
9.55 |
1.26 |
0.65 - 2.20 |
| Lupus |
16 |
13.91 |
1.15 |
0.66 - 1.86 |
* Significantly higher (at the 5% level) than
expected.
| Table 21 Randall County 1980-1994 Selected Diseases and Age, Race-Adjusted Standardized Mortality Ratios |
||||
|
Males | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
2 |
3.62 |
0.55 |
0.07 - 1.99 |
| Multiple Sclerosis |
2 |
1.97 |
1.02 |
0.12 - 3.66 |
| Amyotrophic Lateral Sclerosis |
12 |
8.10 |
1.48 |
0.77 - 2.59 |
| Lupus |
0 |
2.57 |
-- |
-- |
|
Females | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
1.50 |
-- |
-- |
| Multiple Sclerosis |
10 |
3.45 |
2.90* |
1.39 - 5.33 |
| Amyotrophic Lateral Sclerosis |
8 |
6.85 |
1.17 |
0.50 - 2.30 |
| Lupus |
5 |
8.63 |
0.58 |
0.19 - 1.35 |
* Significantly higher (at the 5% level) than expected.
Appendix E
| Table 22 Potter/Randall Counties
Combined 1980-1994 Selected Diseases and Age, Race-Adjusted Standardized Mortality Ratios |
||||
|
Males | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
11 |
7.58 |
1.45 |
0.72 - 2.60 |
| Multiple Sclerosis |
7 |
4.09 |
1.71 |
0.69 - 3.53 |
| Amyotrophic Lateral Sclerosis |
29 |
17.99 |
1.62* |
1.08 - 2.32 |
| Lupus |
5 |
6.25 |
0.80 |
0.26 - 1.86 |
|
Females | ||||
|
Disease |
Observed | Expected | SMR | 95% CI |
| Muscular Dystrophy |
0 |
3.33 |
-- |
-- |
| Multiple Sclerosis |
15 |
7.42 |
2.02* |
1.13 - 3.34 |
| Amyotrophic Lateral Sclerosis |
20 |
16.41 |
1.22 |
0.74 - 1.88 |
| Lupus |
21 |
22.54 |
0.93 |
0.58 - 1.43 |
* Significantly higher (at the 5% level) than expected.
Next Section Table of Contents
